Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Nutritional Approach for the Management of Chemotherapy-Induced Diarrhea in Patients with Colorectal Cancer. | Nutrients | 2022 | 35565769 | PubTator, text mining | PubMed |
| Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment. | Cancers (Basel) | 2022 | 35565311 | PubTator, text mining | PubMed |
| Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed? | Oncologist | 2022 | 35552754 | PubTator, text mining | PubMed |
| Genome-wide tandem repeat expansions contribute to schizophrenia risk. | Mol Psychiatry | 2022 | 35546631 | PubTator, text mining | PubMed |
| Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer. | PLoS One | 2022 | 35544539 | PubTator, text mining | PubMed |
| Advancing Pharmacogenomics from Single-Gene to Preemptive Testing. | Annu Rev Genomics Hum Genet | 2022 | 35537468 | PubTator, text mining | PubMed |
| Identification of heritable rare variants associated with early-stage lung adenocarcinoma risk. | Transl Lung Cancer Res | 2022 | 35529798 | PubTator, text mining | PubMed |
| The Roles of Non-Coding RNAs in Radiotherapy of Gastrointestinal Carcinoma. | Front Cell Dev Biol | 2022 | 35517505 | PubTator, text mining | PubMed |
| Deconstructing ADAURA: It is Time to Forgo Adjuvant Platinum-Based Chemotherapy in Resected IB-IIIA EGFR+ NSCLC (Except with RB Alterations?) When Adopting Adjuvant Osimertinib. | Lung Cancer (Auckl) | 2022 | 35506019 | PubTator, text mining | PubMed |
| Sex-specific extracellular matrix remodeling during early adipogenic differentiation by gestational bisphenol A exposure. | Chemosphere | 2022 | 35504463 | PubTator, text mining | PubMed |
| Pathogenic variants carrier screening in New Brunswick: Acadians reveal high carrier frequency for multiple genetic disorders. | BMC Med Genomics | 2022 | 35488281 | PubTator, text mining | PubMed |
| Racial and ethnic differences in capecitabine toxicity in patients with gastrointestinal tract cancers. | Ann Gastroenterol | 2022 | 35479584 | PubTator, text mining | PubMed |
| Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy. | J Hematol Oncol | 2022 | 35477416 | PubTator, text mining | PubMed |
| Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2022 UK patients. | BMC Cancer | 2022 | 35473510 | PubTator, text mining | PubMed |
| Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand-foot syndrome. | Int J Cancer | 2022 | 35467766 | PubTator, text mining | PubMed |
| Concurrent RAS and RAS/BRAF V600E Variants in Colorectal Cancer: More Frequent Than Expected? A Case Report. | Front Oncol | 2022 | 35463316 | PubTator, text mining | PubMed |
| Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases. | Molecules | 2022 | 35458666 | PubTator, text mining | PubMed |
| FV-100 for the Treatment of Varicella-Virus (VZV) Infections: Quo Vadis? | Viruses | 2022 | 35458500 | PubTator, text mining | PubMed |
| Promising Genomic Testing for Biliary Tract Cancer Using Endoscopic Ultrasound-Guided Fine-Needle Aspiration/Biopsy Specimens. | Diagnostics (Basel) | 2022 | 35453948 | PubTator, text mining | PubMed |
| Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome Sequencing. | J Mol Diagn | 2022 | 35452844 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=45